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Abstract Pediatric MS tends to present more often with
an acute onset and a polysymptomatic form of the disease,
possibly with encephalopathy and large tumefactive lesions
similar to those observed in some cases of acute dissemi-
nated encephalomyelitis (ADEM), which makes it more
difﬁcult to differentiate between an explosive and severe
onset of MS vs. ADEM. An ADEM-like ﬁrst demyelinat-
ing event can be the ﬁrst attack of pediatric MS, but
international consensus deﬁnitions require two or more
non-ADEM demyelinating events for diagnosis of MS. In
our patient KIDMUS MRI criteria for MS (Mikaeloff et al.
J Pediatr 144:246–252, 2004a; Mikaeloff et al. Brain
127:1942–1947, 2004b) were negative at ﬁrst attack, but
Barkhof criteria for lesion dissemination in space in adults
(Barkhof et al. 120:2059–2069, 1997), Callen modiﬁed
MS-criteria and Callen MS-ADEM criteria for children
(Callen et al. Neurology 72:961–967, 2009a; Callen et al.
Neurology 72:968–973, 2009b) were positive suggesting
pediatric MS. As the clinical course was devastating with
non-responsiveness upon high-dose immune modulatory
therapy and due to the absence of an alternative diagnosis
other than demyelinating disease brain biopsy was per-
formed. Brain biopsy studies or autopsy case reports of
fulminant pediatric MS patients are extremely rare. His-
topathology revealed an inﬂammatory demyelinating CNS
process with conﬂuent demyelination, indicating the like-
lihood of a relapsing disease course compatible with an
acute to subacute demyelinating inﬂammatory disease.
This pattern was corresponding to the early active multiple
sclerosis subtype I of Lucchinetti et al. (Ann Neurol
47(6):707–717, 2000).
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Case report
Clinical course
A 16-year old female presented with a 2-week history of
numbness of the right facial skin, parasthesia of the right
upper and lower lip, diplopia, parasthesia and palsy of the
right hand, and incipient hemiparesis of the right leg. Upon
admission the patient was afebrile and her medical history
did not include an acute or prior infection and no past
neurological illnesses. Her birth history and postnatal
development had been unremarkable. Vital signs were
stable and her mental status was intact. Physical exami-
nation revealed a lack of sensitivity of the right facial skin,
pronounced diplopia when looking to the left, a slight
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DOI 10.1007/s00702-011-0609-6weakness of the right upper extremity, a pronounced
weakness of the right lower extremity, and weak dorsi-
ﬂexion of the right foot.
Initial laboratory studies showed no abnormalities.
Lumbar puncture and cerebrospinal ﬂuid (CSF) analysis
indicated a normal opening pressure with macroscopically
clear CSF, total protein levels of 369 mg/l with an albumin
level of 253 mg/l, lactate of 1.38 mmol/l, and glucose of
58.7 mg/dl. White blood cell count was elevated at 26/ll
including a majority of immunoreactive lymphocytes and
monocytes. No erythrocytes were present. The sample
showed type-3-oligoclonal bands accompanied by intra-
thecal synthesis of immunoglobulin G. The CSF/Serum
glucose index was normal. Gram stains, blood cultures, and
serological analysis were negative. The pleocytosis in the
CSF led to the administration of an antibiotic and antiviral
medication from day one. Cranial magnetic-resonance-
imaging (MRI) revealed extensive tissue defects with
restricted diffusion indicating an acute demyelinating
process. Thereupon treatment with high-dose methylpred-
nisolone (1 g/day) was started.
On the second day after hospital admission the patient’s
neurological status declined progressively. In the morning
she displayed anxiety, states of sudden arousal, as well as
reduced vigilance and consciousness. The hemiparesis of
the right lower leg became evident and she was unable to
ambulate. Reﬂexes as well as superﬁcial, noxious and deep
sensation of the lower limbs were absent. Visual acuity was
limited to hand movement and ﬁnger counts with bitem-
poral hemianopia. She showed dysphagia and dysarthria, as
well as incipient urinary and stool incontinence. Visual
evoked potential amplitudes were found to be reduced and
latencies of bilateral contracortical waves were clearly
prolonged. At the end of this day, the patient was blind,
presenting spastic tetraparesis, complete urinary and stool
incontinence, and complete loss of consciousness. Sudden
respiratory paralysis led to admission to the intensive care
unit where tracheal intubation and assisted ventilation were
initiated. The patient’s condition declined rapidly. The
need for brain biopsy became inevitable due to the lack of a
differential diagnosis other than demyelinating disease, as
well as due to the patient’s non-responsiveness towards
high-dose corticosteroid treatment and plasmapheresis.
Following this, therapy with double the dosage of meth-
ylprednisolone (2 g/day) was recommended for ﬁve more
days.
Neuroimaging ﬁndings
On day one of hospital admission an initial MRI scan of the
brain was performed. MR images were acquired on a 3
tesla magnet with slice thickness between 2 and 5 mm and
an interslice gap of up to 2 mm. T2-weighted images
showed multiple periventricular and deep white matter
focal lesions (Fig. 1a), one juxtacortical lesion of the left
precentral region, involvement of the corpus callosum as
well as one hyperintense lesion within the right brachium
pontis (Fig. 1b) associated diffuse hyperintense changes.
Fluid attenuated inversion recovery (FLAIR) sequence
revealed multiple hyperintense areas, including oval
lesions within the periventricular white matter (PVWM)
and the corpus callosum (Fig. 1c). The lesions were ori-
ented perpendicular to the long axis of the ventricular
system. Diffusion weighted image (DWI) showed restric-
ted diffusion as a feature of inﬂammatory disease activity.
Large lesions were seen in the centrum semiovale bilater-
ally with ill-deﬁned borders, presence of mass defect and
marked restriction in diffusion images (Fig. 1d). Apparent
diffusion coefﬁcient (ADC) maps (Fig. 1e) clearly showed
reduced signal, indicating the presence of cytotoxic edema
(Axer et al. 2005).
T1-weighted images after contrast (gadolinium) showed
enhancement within the PVWM (Fig. 1f) as well as in the
right cerebellar peduncle corresponding to the described
lesions of T2 and FLAIR sequences representing areas of
active demyelination. All hyperintense lesions in T2
weighted imaging described above were concordant with
hypointense areas in T1 weighted images compared with
white matter and resembling gray matter. T2* sequences
showed no sign of intracranial bleeding or vascular lesions.
There was no evidence for intracranial neoplasm or vas-
culitis. Cerebral ﬂuid interspaces were of normal age-
matched width and there was no sign of elevated cranial
pressure.
Follow-up MRI performed on day four of hospital
admission showed an increase of the tumefactive demye-
linating lesions, particularly in the PVWM. The number of
diffuse ovoid lesions in T2 and FLAIR images increased
with further spread towards the truncus and splenium of the
corpus callosum. There was a progression of the active
demyelinating lesions with mass defect including the
involvement of the subcortical white matter. Axial T1-
weighted image showed large bilaterally hypointense
lesions with signs of cystic necrotic changes concordant
with hyperintense areas in axial T2w sequences (Fig. 1g).
The known lesion of the right cerebellar peduncle was
unchanged.
Altogether, the patient was positive when applying the
following diagnostic MRI criteria: Barkhof criteria for
lesion dissemination in space in adults (Barkhof et al.
1997), Callen modiﬁed MS-criteria for children (Callen
et al. 2009a, b), and Callen MS-acute disseminated
encephalomyelitis (MS-ADEM) criteria for children
(Callen et al. 2009a, b). Negative results were obtained
when applying KIDMUS criteria to our patient (Mikaeloff
et al. 2004a, b).
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Materials and methods
Neuropathological examination: Intraoperative diagnostics
consisted of cytological evaluation of smears stained with
methylene blue. Parafﬁn-embedded tissue was investigated
using classical hemalaun eosin (HE) stains followed by
periodic acid Schiff stainings, Klu ¨ver–Barrera and reticulin
stainings as well as immunohistochemistry for CD68
(microglia/macrophages), CD4 (T-helper cells), CD8
(cytotoxic T-cells), CD20 (B-cells), neuroﬁlament (axonal
structures), glial ﬁbrillary acid protein (reactive astrocytes),
the monoclonal antibody MIB-1 (proliferation index),
C9neo (complement deposits), and CNPase (20,30-cyclic
nucleotide-3-phosphohydrolase). Evaluation of the histo-
logical and immunohistochemical stainings and photo-
graphic documentation were performed using an Olympus
BX-40 light microscope (Hamburg, Germany). Pictures
were taken with a digital camera (Olympus, DP72, Ham-
burg, Germany). Furthermore electron microscopy was
performed of selected areas using a FEI Tecnai G2 Spirit
Biotwin electron microscope (Hillsboro, OR).
Results
Stereotactic biopsy tissue showed signs of brain edema
accompanied by astrogliosis and a moderate increase in
cellularity (Fig. 2a). Single Creutzfeldt–Peters cells were
observed (Fig. 2a; inset). Besides, small necrotic foci were
present. Myelin-speciﬁc stainings revealed dystrophic
axonal spheroids and severe loss of myelin (Fig. 2b).
Immunohistochemical examination conﬁrmed the demye-
linating character of the lesion in which a massive inﬁl-
tration of foamy macrophages and activated microglial
cells was seen (Fig. 2c) while axons were mainly preserved
(Fig. 2d). The main population of diffusely intermingled
inﬂammatory cells consisted of CD8-positive cytotoxic
T-cells. No hints of a vasculitis or other inﬂammatory CNS
diseases as discussed in the clinical differential diagnoses
were seen. No complement deposits could be detected in
the biopsies. On an ultrastructural level, both active
demyelination (so-called myelin stripping by monocytic
cells; Fig. 2e) and completely demyelinated axons (so-
called nude axons; Fig. 2f) were observed. Especially, the
prominent signs of myelin stripping indicate an early active
demyelinating lesion. There were no classical morpholog-
ical ﬁndings supporting the differential diagnosis of an
acute demyelinating encephalomyelitis disseminata such as
a perivenular demyelination pattern (Pittock et al. 2005). In
contrast, an MS typical conﬂuent demyelination pattern
was observed. Thus the T-cell/macrophage-mediated
myelin destruction without deposition of activated com-
plement on degenerating myelin sheaths or within the
cytoplasm of inﬁltrating macrophages could be classiﬁed
as pattern I according to Lucchinetti et al. (Lucchinetti
et al. 2000).
Fig. 1 a Axial T2-weighted image of the initial disease stage shows
multiple periventricular and deep white focal lesions associated with
diffuse hyperintense changes. b T2-weighted image showing hyper-
intensity of the pons. c The focal lesions were hyperintense on FLAIR
image. d Diffusion-weighted image showed restricted diffusion,
conﬁrmed by the Apparent diffusion coefﬁcient (ADC) maps. e ADC
maps showing reduced signal, indicating the presence of cytotoxic
edema. f T1-weighted image of gadolinium enhancing lesions within
the centrum semiovale of both hemispheres. g Axial T1-weighted
image showing large bilaterally hypointense lesion with small areas
of tissue defect concordant with hyperintensity in T2-weighted image
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The patient was extubated on day 19 after hospital
admission. On day 29 of hospital admission she was
transferred to a neurorehabilitative hospital. The MRI
control 8 weeks after therapeutic treatment with plasma-
pheresis for 7 days and administration of double the dosage
of methylprednisolone for 5 days showed complete
regression of the enhancing lesions with no restricted dif-
fusion on DWI.
Sixmonthsaftertheﬁrstevent,thepatientshowedasecond
monosymptomatic event without encephalopathy suffering
from numbness of the left lower leg. No MRI was performed
then.Another6 monthslaterthepatientpresentedwithathird
monosymptomatic demyelinating attack without signs of
encephalopathy involving new areas of the CNS. She dis-
playedsensorydisturbancesintheroofofthemouth,aswellas
of the right side of the face. The MRI showed one new gad-
olinium-enhancing lesion located within the right pons near
the rootlets of the trigeminal nerve (not shown) fulﬁlling
McDonald revised MS diagnostic criteria of lesion dissemi-
nation in time (Polman et al. 2005). T1 weighted images
showed persisting hypointense lesions, so called persistent
black holes (Sahraian et al. 2010)o ft h eP V W M .
The patient received methylprednisolone (1 g/day) for
3 days whereupon symptoms decreased.
Fig. 2 Histology/
immunohistochemistry/electron
microscopy. a The biopsy
specimen showed CNS tissue
with a moderate increase in
cellularity, reactive gliosis,
edema, and some dilated blood
vessels (HE); single
Creutzfeldt–Peters cells were
seen (inset). b A severe loss of
myelination was seen with only
few remaining myelinated
axons (Klu ¨ver–Barrera).
c Massive macrophage/
microglia inﬁltration was
observed in the stereotactic
biopsies (CD68) while d axonal
structures were preserved
(neuroﬁlament). At the
ultrastructural level, both
e active demyelination (arrow
indicating a macrophage
surrounding an axon) and
almost f completely
demyelinated axons (arrow)
were present
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Pediatric MS tends to present more often with an acute
onset and a polysymptomatic form of the disease, possibly
with encephalopathy and large tumefactive lesions similar
to those observed in some cases of ADEM, which makes it
more difﬁcult to differentiate between an explosive and
severe onset of MS vs. ADEM (Mikaeloff et al. 2004a, b,
2007; Dale and Pillai 2007). An ADEM-like ﬁrst demye-
linating event can be the ﬁrst attack of pediatric MS, but
international consensus deﬁnitions require two or more
non-ADEM demyelinating events for diagnosis of MS
(Krupp et al. 2007). MRI is a useful tool in making the
diagnosis of acute inﬂammatory demyelination and might
be helpful in recognizing patients who are at risk of future
attacks of demyelination. When polyfocal demyelination is
accompanied by encephalopathy, the clinical diagnosis of
ADEM is applied (Krupp et al. 2007). MRI features of
ADEM typically include widespread, bilateral, and asym-
metric involvement of supratentorial and infratentorial
white matter and deep gray nuclei as partially seen in our
patient. On the other hand, in approximately 20% of chil-
dren who are initially diagnosed with ADEM subsequent
multiple attacks lead to the diagnosis of MS (Mikaeloff
et al. 2004a, b, 2007; Dale and Pillai 2007; Neuteboom
et al. 2008; Banwell et al. 2007).
Two sets of MRI criteria designed for predicting con-
version to MS after a ﬁrst demyelinating event, the Barkhof
MRI-criteria for adults (Barkhof et al. 1997) and the
KIDMUS criteria for children (Mikaeloff et al. 2004a, b),
were applied to our patient at ﬁrst demyelinating event
(Table 1). While Barkhof criteria of lesion dissemination in
space turned positive during the patient’s ﬁrst demyelin-
ating event, KIDMUS criteria remained negative due to
the required presence of a solely discrete lesion pattern
(Mikaeloff et al. 2004a, b). Of interest here is that in a
recent study by Callen et al. (2009a, b) 65% of pediatric
patients with ﬁrst onset of MS had at least one large lesion
(C2 cm in diameter) (Callen et al. 2009a, b). The occur-
rence of large lesions in children with MS has been
reported previously (Gallucci et al. 2001; Ruggieri et al.
2004). In another comparative study both sets of criteria,
Barkhof and KIDMUS criteria, have been shown to have a
high speciﬁcity and positive predictive value in predicting
conversion to a clinically deﬁnite MS but show low sen-
sitivity in children under age of 10 years (Ketelslegers
et al. 2010).
Hahn et al. (2004) already reported that adult-based
MRI diagnostic criteria were not as sensitive to the
appearance of MS in children. This led Callen et al. (2009a,
b) to a revision and modiﬁcation of the McDonald criteria
for lesion dissemination in space in order to better distin-
guish pediatric MS from nondemyelinating diseases in
childhood. The criteria by Callen differed from the
McDonald criteria for MS in adults by requiring two or
more of (rather than three criteria) (1) CT2 rather than
more than 9 T2 lesions (2) C2 periventricular lesions rather
than C3, and (3) C1 brainstem rather than C1 infratentorial
lesion. The criterion of C1 juxtacortical lesion was not
found to contribute to the pediatric MRI criteria, and
gadolinium-enhancing lesions were not included because
many children of the cohort studied by Callen et al. did not
receive gadolinium. Application of adult MS McDonald
criteria for dissemination in space to the pediatric cohort of
Callen et al. produced a sensitivity of only 76% as com-
pared with the 85% sensitivity of the proposed criteria.
Applying the Callen modiﬁed MS- criteria to our patient
we also received a positive result suggesting the diagnosis
of MS (Table 1). Though Callen noted that these new
pediatric MS criteria were met not only by 75% of the 28
children with ﬁrst attack of MS examined by this study but
at the same time also by 75% of the children with ADEM
indicating that the criteria were a valid means of distin-
guishing MS from nondemyelinating acute neurologic
disorders in children but that they might lack the speciﬁcity
to distinguish between pediatric MS and ADEM. These
results led him to a second revision of the diagnostic MRI
criteria available in order to determine MRI diagnostic
criteria that better differentiated between pediatric MS and
monophasic demyelination (ADEM) (Callen et al. 2009a,
b). Out of a comprehensive quantitative and qualitative
analysis of MRI obtained at a ﬁrst attack of pediatric MS
and ADEM, Callen et al. (2009a, b) proposed the following
criteria: any two of (1) absence of a diffuse bilateral lesion
pattern, (2) presence of black holes, and (3) presence of
two or more periventricular lesions. Applying these criteria
MS patients at ﬁrst attack could be distinguished from
monophasic ADEM patients with an 81% sensitivity and a
95% speciﬁcity. Using these criteria in our patient they also
were positive indicating a relapsing demyelinating disease
course of MS.
Nevertheless, in our patient the clinical course was
devastating, resulting in stereotactic brain biopsy. Histo-
pathology revealed an inﬂammatory demyelinating CNS
process with a conﬂuent demyelination, inﬂammation,
reactive gliosis, and relative axonal preservation. A mas-
sive inﬁltration by foamy macrophages and a few T-cells
could be observed. LFB- and CNPase-positive myelin
degradation products were detectable within the cytoplasm
of some macrophages, indicating an early active demye-
linating lesion. Small areas of remyelination could be seen.
Deposition of activated complement was absent. No hints
for a vasculitis or other inﬂammatory CNS diseases as
discussed in the clinical differential diagnoses were seen,
and there were no classical morphological ﬁndings sup-
porting the differential diagnosis of an acute demyelinating
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demyelination pattern (Pittock et al. 2005). The present
case was compatible with an acute to subacute demyelin-
ating inﬂammatory disease corresponding to the early
active multiple sclerosis subtype I according to the classi-
ﬁcation of Lucchinetti et al. (2000). The presence of CNP
within macrophages indicated an early demyelination.
Subtype II (antibody/complement associated) could be
ruled out by the lack of C9neo deposits. Since there were
oligodendrocytes forming new thin myelin sheets within
the lesions, subtypes III (oligodendrogliopathy) and IV
(oligodendrocyte degeneration in the periplaque white
matter) were as well unlikely.
Brain biopsy studies or autopsy case reports of pediatric
MS patients are rare. Even more rare are biopsy specimen
out of large ill deﬁned ADEM like MS-lesions in a pedi-
atric/adolescent patient. Up to now there are no reports or
studies on speciﬁc histopathological ﬁndings in pediatric
MS (Pohl 2008). Pathological ﬁndings in adult MS cohorts
demonstrate heterogeneity, classiﬁable into the upper
mentioned four subtypes. Though, it remains unclear
whether these four distinct pattern are generally applicable
to pediatric MS patients.
From clinical point of view according to the consensus
deﬁnitions of the International Pediatric MS Study Group,
our patient did not fulﬁll the diagnostic criteria for MS at
ﬁrst onset of the disease (Krupp et al. 2007) due to the
absence of multiple demylinating events separated in time
and space and due to the presence of encephalopathy at ﬁrst
attack. Consensus deﬁnitions require a third clinical and/or
new T2-lesions at least 3 months from the second event to
be diagnosed with MS. These criteria were met by the
patient 12 months after initial attack. The patient did not
meet recurrent or multiphasic ADEM criteria at second and
third event (Krupp et al. 2007).
Taken together, neuroradiologic MRI criteria were incon-
sistent with positive Callen MS-ADEM criteria (Callen et al.
2009a, b) which have been shown to possibly be the most
useful MRI criteria for differentiating pediatric ﬁrst MS from
ADEM (Ketelslegers et al. 2010); histopathologic ﬁndings
indicated an early active multiple sclerosis subtype I (Luc-
chinetti et al. 2000), but clinical features contradicted the
presence of MS and indicated ADEM (Krupp et al. 2007).
Regarding the rarity of fulminant MS variants, there is no
uniform treatment strategy. It is known that patients with
MS may beneﬁt from early aggressive therapy during the
initial clinical event (Young et al. 2010). Hence, an intensi-
ﬁed immunomodulatory treatment might have prevented a
continuing inﬂammatory disease activity in our patient.
Our ﬁndings reﬂect the current problem of diverse and
inconsistent ﬁndings in pediatric MS. The importance of
further differentiating MRI-criteria for children under
10 years (or child vs. adolescent) has been noted by other
researchers also (Callen et al. 2009a, b) and might be
underlined by our ﬁndings. It is unclear whether lesion
pattern of pediatric MS might change with age of onset,
Table 1 Comparison of
different MS–MRI diagnostic
criteria applied to our patient at
ﬁrst demyelinating event
Different MRI-criteria for MS published recently Patient’s ﬁrst
demyelinating attack
KIDMUS (Mikaeloff et al. 2004a, b)
All of:
C1 lesion perpendicular to long axis of corpus callosum Yes
Presence of solely discrete lesions (B2 cm in diameter) No
McDonald (Barkhof et al. 1997)
At least three of:
C9 T2 lesions or C1 gadolinium enhancing lesion Yes
C3 periventricular Yes
C1 juxtacortical Yes
C1 infratentorial (or spinal) lesion Yes
Callen modiﬁed MS-criteria (Callen et al. 2009a, b)
At least two of:
C5 T2 lesions Yes
C2 periventricular Yes
C1 brainstem Yes
Callen MS-ADEM criteria (Callen et al. 2009a, b)
Any two of:
Absence of diffuse bilateral lesion pattern No
Presence of black holes Yes
Presence of two or more periventricular lesions Yes
1316 F. Hoche et al.
123and possibly in our patient there already was a more adult-
speciﬁc lesion pattern leading to a positive matching of
pediatric and adult MRI criteria. Second, Callen et al.
(2009a, b) proposed further work up on a suggested shift of
diffuse lesion pattern of a ﬁrst ADEM-like MS event from
large mass-like lesions to more MS-like, single-shaped
lesions in older children and adolescents and that further
research on the presence of gadolinium-enhancing lesion
pattern in children and adults with MS was required.
Fourth, pediatric histopathologic and CSF biomarker
studies might be necessary to further discuss differences in
neurorehabilitative potential of pediatric MS patients,
possible implications for treatment strategies, and concor-
dance with current histopathological classiﬁcation in adults
(Lucchinetti et al. 2000).
Our report aims at broadening the understanding of the
clinical course, histopathologic and neuroradiologic fea-
tures of pediatric ADEM-like ﬁrst demyelinating attacks
converting to MS during disease course. In our patient we
had the rare chance to investigate stereotactic brain biopsy
specimen in a pediatric patient with such initial fulminant
variant of MS. We ﬁnd it important to share the experience
of different treatment procedures in fulminant MS variants
with other researchers and hope to contribute diagnostic
data for future revisions on MS classiﬁcations in order to
further specify MS patient cohorts.
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